The CPhM Resource Library features the documents, guidelines, legislation, and more to inform your pharmacy practice. Use the "Filter by category" tool to improve your search.
Found 29 Results
| Title | Category | Type | Date posted |
CAMH Buprenorphine/Naloxone for Opioid Dependence: Clinical Use Guide |
Guidelines Opioids and Opioid Agonist Therapy |
External Link | |
CAMH Methadone Maintenance Treatment – Client Handbook Revised |
Guidelines Opioids and Opioid Agonist Therapy |
External Link | |
CAMH Opioid Agonist Maintenance Treatment: A Pharmacist’s Guide to Methadone and Buprenophine for Opioid Use Disorder |
Guidelines Opioids and Opioid Agonist Therapy |
External Link | |
Canadian Pharmacists Association – Opioid Crisis and Naloxone Resources |
Naloxone Opioids and Opioid Agonist Therapy |
External Link | |
Companion Document to the CPSM Standards of Practice for Prescribing Opioids and Benzodiazepines and Z-Drugs |
Opioids and Opioid Agonist Therapy |
April 2021 | |
CPhM Methadone Maintenance Treatment: Quick Guide to Keep Your Patients, Staff, and Community Safe |
Guidelines Opioids and Opioid Agonist Therapy |
June 2020 | |
Find Naloxone |
Naloxone Opioids and Opioid Agonist Therapy |
Internal Link | |
Giving Naloxone (an antidote for opioid overdoses) |
Naloxone Opioids and Opioid Agonist Therapy |
External Link | |
Guidance on the Administration of Sublocade by a Pharmacist |
Opioids and Opioid Agonist Therapy |
December 2020 | |
Health Canada – Canada’s Opioid Crisis |
Opioids and Opioid Agonist Therapy |
External Link | |
How to use naloxone nasal spray in a few simple steps (video) |
Naloxone Opioids and Opioid Agonist Therapy |
External Link | |
Manitoba Health Training Manual: Overdose Prevention, Recognition, and Response |
Newsletter Opioids and Opioid Agonist Therapy |
External Link | |
Manitoba Information on Fentanyl |
Information Opioids and Opioid Agonist Therapy |
External Link | |
Manitoba Opioid Agonist Therapy Recommended Manual |
Opioids and Opioid Agonist Therapy |
External Link | |
Methadone for Pain in Palliative Care |
Opioids and Opioid Agonist Therapy |
External Link | |
Naloxone Brochure for Ampoules (Patient Resource) |
Naloxone Opioids and Opioid Agonist Therapy |
June 2020 | |
Naloxone Brochure for Vials (Patient Resource) |
Naloxone Opioids and Opioid Agonist Therapy |
December 2020 | |
Naloxone Injection Training Checklist |
Naloxone Opioids and Opioid Agonist Therapy |
June 2020 | |
Naloxone Listing – How to Add Your Pharmacy |
Naloxone Opioids and Opioid Agonist Therapy |
Internal Link | |
Naloxone Nasal Spray Brochure (Patient Resource) |
Naloxone Opioids and Opioid Agonist Therapy |
December 2020 | |
Naloxone Nasal Spray Training Checklist |
Naloxone Opioids and Opioid Agonist Therapy |
June 2020 | |
Naloxone Training and Resources (Toward the Heart) |
Naloxone Opioids and Opioid Agonist Therapy |
External Link | |
Naloxone: Frequently Asked Questions |
Naloxone Opioids and Opioid Agonist Therapy |
December 2020 | |
Opioid Agonist Therapy Guidelines for Manitoba Pharmacists |
Guidelines Opioids and Opioid Agonist Therapy |
December 2020 | |
Smart Medication Agenda: Fentanyl |
Opioids and Opioid Agonist Therapy Safety IQ |
August 2018 | |
SMART Medication Safety Agenda: Methadone |
Opioids and Opioid Agonist Therapy Safety IQ |
December 2020 | |
Take-Home Naloxone Distribution Program (for Service Providers) |
Naloxone Opioids and Opioid Agonist Therapy |
External Link | |
Toward the Heart: Naloxone Course |
Naloxone Opioids and Opioid Agonist Therapy |
External Link | |
Two Federal Exemptions Applicable to Opioid Agonist Therapy |
Opioids and Opioid Agonist Therapy |
September 2020 |